Our Research Results

Since we first began more than 40 years ago, Breast Cancer Trials (BCT) has contributed to more than 1,200 peer-reviewed publications and many of these research results have changed practice in the treatment and prevention of breast cancer.

The publication of the results of clinical trials research in a scientific journal or a periodic publication:

  • Fulfils the researchers’ ethical obligations to research participants and the general community;
  • Contributes to medical knowledge so doctors can make scientifically valid assessments of the benefits and risks of a new medicine or treatment for their patients.

BCT publishes study results in accordance with the BCT Publication Policy.

The citations for all of these publications are listed below, ordered by year. To search for a citation, enter a keyword/s and click search. Enclose multiple words in quotes “” to search for an exact match. Alternatively, you can search for clinical trials in a given year or for a particular clinical trial name. 

The majority of the publications can be accessed via PubMed, other research databases or publication storage systems at a university library (if you are a student/member), or directly to the journal or publication online. Many scientific journals provide articles as “open access”; however some require a subscription.

PUBLICATIONS

2024

Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials.

Early Breast Cancer Trialists’ Collaborative Group. The Lancet. 2024; 4041407-18, epub 12 October 2024, E-pub

Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.

Loibl S, Jassem J, Sonnenblick A, Parlier D, Winer E, Bergh J, Gelber RD, Restuccia E, Im Y-H, Huang C-S, Dalenc F, Clavo I, Procter M, Caballero C, Clark E, Raimbault A, McConnell, Monturus E, de Azambuja E, Gomez HL, Bliss J, Viale G, Bines J, Piccart M, on behalf of the APHINITY Steering Committee and Investigators. Journal of Clinical Oncology. 2024; 0, JCO.23.02505; DOI:10.1200/JCO.23.02505, E-pub

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].

de Azambuja D, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, Kelly CM, Lombard J, El-Abed S, Choudhury A, Korde L, Vicente M, Chumsri S, Rodeheffer R, Ellard SL, Wolff AC, Holtschmidt J, Lang I, Untch M, Boyle F, Xu B, Werutsky G, Tujakowski J, Huang C-S, Burach NB, Bliss J, Ferro A, Gralow J, Kim S-B, Kroep JR, Krop I, Kuemmel S, McConnell R, Moscetti L, Knop AS, van Duijnhoven F, Gomez H, Cameron D, Di Cosimo S, Gelber RD, Moreno-Aspitia A. ESMO Open. 2024; 9(11):https://doi.org/10.1016/j.esmoop.2024.103938, E-pub

Breast cancer index in premenopausal women with early-stage hormone receptor-positive breast cancer.

O’Regan RM, Zhang Y, Fleming GF, Francis PA, Kammler R, Viale G, Dell’Orto P, Lang I, Bellet M, Bonnefoi HR, Tondini C, Villa F, Bernardo A, Ciruelos EM, Neven P, Karlsson P, Muller B, Jochm W, Zaman K, Marino S, Geyer CE, Jerzak KJ, Davidson NE, Coleman RI, Ingle JN, van Mackelenbergh MR, Loi S, Colleoni M, Schnabel CA. JAMA Oncology. 2024; epub 15 August 2024; doi:10.1001/jamaoncol.2024.3044, E-pub

Adjunctive statistical standardization of adjuvant estrogen receptor and progesterone receptor in Canadian Cancer Trials Group MA.27 postmenopausal breast cancer trial of exemestane versus anastrozole.

Chapman J-AW, Bayani J, SenGupta S, Bartlett JMS, Piper T, Quintayo MA, Virk S, Goss PE, Ingle JN, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Tozer R, D’Souza DP, Chalcal H, Spadafora S, Stearns V, Perez EA, Gelmon KA, Whelan TJ, Elliot C, Shepherd LI, Chen BE, Taylor KJ. Journal of Clinical Oncology. 2024; 42(24):2887-2898, Journal

Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility. [BCT Clinical Fellowship].

Yeh, J, Chew G, Ng SL, Ooi WM, Loh S-W, Hyett A, Leech T, Bevington E, Huynh J, Sim J, Foroudi F, Ng SP, Chao M. Clinical and Translational Radiation Oncology 2024; 45100745; https://doi.org/10.1016/j.ctro.2024.100745, E-pub

Total Publications: 1320